Molecular cloning and expression of an avian G proteincoupled P2Y receptor

Molecular Pharmacology

Volumn 52, Issue 6, 1997, Pages 928-934

  Boyer, José L ^a   Waldo, Gary L ^a   Harden, T Kendall ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN; PHOSPHOLIPASE C; PURINE P2 RECEPTOR; URIDINE TRIPHOSPHATE;

ARTICLE; ASTROCYTOMA CELL; HUMAN; HUMAN CELL; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN SYNTHESIS REGULATION; RECEPTOR AFFINITY; RECEPTOR DENSITY; SEQUENCE HOMOLOGY; TURKEY (BIRD);

EID: 0031466317     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.52.6.928     Document Type: Article

References (39)

1. 2-purinergic receptors for extracellular ATP and other nucleotides. Am. J. Physiol. 265:C577-C606 (1993).
2. 2-purinergic receptors: subtype-associated signaling responses and structure. Annu. Rev. Pharmacol. Toxicol. 35:541-579 (1995).
3. 2Y purinoceptors? Pharmacol. Ther. 64:445-475 (1994).
4. Fredholm, B. B., M. P. Abbracchio, G. Burnstock, J. W. Daly, T. K. Harden, K. A. Jacobson, P. Leff, and M. Williams. Nomenclature and classification of purinoceptors. Pharmacol. Rev. 46:143-156 (1994).
5. Fredholm, B. B., G. Burnstock, T. K. Harden, and M. Spedding. P2 receptor nomenclature. Drug Dev. Res. 39:461-466 (1997).
6. Webb, T. E., J. Simon, B. J. Krishek, A. N. Bateson, T. G. Smart, B. F. King, G. Burnstock, and E. A. Barnard. Cloning and functional expression of a brain G-protein-coupled ATP receptor. FEBS Lett. 324:219-225 (1993).
7. 1 receptor. Br. J. Pharmacol. 118:167-173 (1996).
8. Communi, D., S. Pirotton, M. Parmentier, and J. M. Boeynaems. Cloning and functional expression of a human uridine nucleotide receptor. J. Biol. Chem. 270:30849-30852 (1995).
9. Nguyen, T., L. Erb, G. A. Weisman, A. Marchese, H. H. Q. Heng, R. C. Garrad, S. R. George, J. T. Turner, and B. F. O'Dowd. Cloning, expression, and chromosomal localization of the human uridine nucleotide receptor gene. J. Biol. Chem. 270:30845-30848 (1995).
10. 2 nucleotide receptor. J. Biol. Chem. 270:26152-26158 (1995).
11. 2 receptors: identification of a UDP-selective, a UTP-selective, and an ATP-and UTP-specific receptor. Mol. Pharmacol. 50:224-229 (1996).
12. Lustig, K. D., A. K. Shiau, A. J. Brake, and D. Julius. Expression cloning of an ATP receptor from mouse neuroblastoma cells. Proc. Natl. Acad. Sci. USA 90:5113-5117 (1993).
13. 3) activated preferentially by nucleoside diphosphates. Mol. Pharmacol. 50:258-265 (1996).
14. 5. Biochem. Biophys. Res. Commun. 219:105-110 (1996).
15. Kaplan, M. H., D. I. Smith, and R. S. Sundick. Identification of a G protein coupled receptor induced in activated T cells. J. Immunol. 151:628-636 (1993).
16. Akbar, G. K M., V. R. Dasari, T. E. Webb, K. Ayyanathan, K. Pillarisetti, A. K. Sandhu, R. S. Athwal, J. L. Daniel, B. Ashby, E. A. Barnard, and S. P. Kunapuli. Molecular cloning of a novel P2 purinoceptor from human erythroleukemia cells. J. Biol. Chem. 271:18363-18367 (1996).
17. 1 receptor. Br. J. Pharmacol. 121:338-344 (1997).
18. Herold, C. L., Q. Li, J. B. Schachter, T. K. Harden, and R. A. Nicholas. Lack of nucleotide-promoted second messenger signaling responses in 1321N1 cells expressing the proposed P2Y receptor, p2y7. Biochem. Biophys. Res. Commun. 235:717-721 (1997).
19. Li, Q., J. B. Schachter, T. K. Harden, and R. A. Nicholas. The 6H1 orphan receptor, claimed to be the p2y5 receptor, does not mediate nucleotide-promoted second messenger responses. Biochem. Biophys. Res. Commun. 236:455-460 (1997).
20. 4 that mediates chemotaxis. Nature (Lond.) 387:620-624 (1997).
21. 11-and βγ-subunit-stimulated PLC-β from avian erythrocytes. Biochem. J. 316:559-568 (1996).
22. Comstock, K. E., N. F. Watson, and J. C. Olsen. Design of retroviral expression vectors. Methods Mol. Biol. 62:207-222 (1997).
23. 1 receptor. Mol. Pharmacol. 50:1323-1329 (1996).
24. Kozak, M. An analysis of 5′ noncoding sequences from 699 vertebrate messenger RNAs. Nucleic Acids Res. 15:8125-8148 (1987).
25. 2Y purinoceptor using rhodopsin as template. Drug Des. Discov. 13:133-154 (1995).
26. 2Y-purinergic receptor that couples to phospholipase C. Mol. Pharmacol. 46:8-14 (1994).
27. 6 receptor. Biochem. Biophys. Res. Commun. 222:303-308 (1996).
28. 2U-purinergic receptor: potent activation by diadenosine tetraphosphate. Br. J. Pharmacol. 116:1619-1627 (1995).
29. Yarden, Y., H. Rodriguez, S. K.-F. Wong, D. R. Brandt, D. C. May, J. Burnier, R. N. Harkins, E. Y. Chen, J. Ramachandran, A. Ullrich, and E. M. Ross. The avian β-adrenergic receptor: primary structure and membrane topology. Proc. Natl. Acad. Sci. USA 83:6795-6799 (1986).
30. Chen, X.-H., T. K. Harden, and R. A. Nicholas. Molecular cloning and characterization of a novel β-adrenergic receptor. J. Biol. Chem. 269: 24810-24819 (1994).
31. Bogdanov, Y. D., L. Dale, B. F. King, N. Wittock, and G. Burnstock. Early expression of a novel nucleotide receptor in the neural plate of Xenopus embryos. J. Biol. Chem. 272:12583-12590 (1997).
32. Vanhoutte, P. M., P. P. A. Humphrey, and M. Spedding. XI. International Union of Pharmacology recommendations for nomenclature of new receptor subtypes. Pharmacol. Rev. 48:1-2 (1996).
33. Fredholm, B. B., M. P. Abbracchio, G. Burnstock, G. R. Dubyak, T. K. Harden, K. A. Jacobson, U. Schwabe, and M. Williams. Towards a revised nomenclature for P1 and P2 receptors. Trends Pharmacol. Sci. 18:79-82 (1997).
34. 2Y receptor. Biochem. Biophys. Res. Commun. 212:648-656 (1995).
35. 2Y purinoceptors. Biochem. Biophys. Res. Commun. 211: 211-218 (1995).
36. Leon, C., C. Vial, J. P. Cazenave, and C. Gachet. Cloning and sequencing of a human cDNA encoding endothelial P2Y1 purinoceptor. Gene 171:295-297 (1996).
37. 1 receptor. Biochem. Biophys. Res. Commun. 221:588-593 (1996).
38. Harden, T. K., L. Stephens, P. T. Hawkins, and C. P. Downes. Turkey erythrocyte membranes as a model for regulation of phospholipase C by guanine nucleotides. J. Biol. Chem. 262:9057-9061 (1987).
39. 1 receptor: pharmacological, signaling, and molecular properties. Drug Dev. Res. 39:253-261 (1996).